Plants Used in Diabetes Treatment

Abstract

Recently, the interest in herbal products is increasing day by day due to the side effects as well as the medical and economic problems. There are different plants used for different diseases and different extracts prepared from certain parts of these plants. In this study, the plants used in the treatment of diabetes were emphasized; In many different countries, including Türkiye, the plants used for this purpose and their parts are mentioned. For this, articles in many indexes were scanned and scientific studies were compiled following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses state-ment. In addition, scientific studies on the plants Panax ginseng C. A. Meyer, Trigonella foenum-graecum L., Cinnamomum cassia Blume, Cinnamomum zeylanicum Nees. and Allium sativum L., which are frequently used in the treatment of diabetes globally, are given in detail. It is also mentioned that these plants are included in pharmacopoeia and monographs. While the place and importance of plants and preparations prepared from plants in medicine and pharmacology is quite large, any work to be done on this subject will shed light on the world of science.

Keywords

• Diabetes
• ; Panax ginseng
• Trigonella foenum-graecum
• Cinnamomum cassia
• Cinnamomum zeylanicum.

References

1. Abdelmoaty, M. A., Ibrahim, M. A., Ahmed, N. S., & Abdelaziz, M. A. (2010). Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian Journal of Clinical Biochemistry, 5, 188-192. https://doi.org/10.1007/s12291-010-0034-x
2. Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010). Toxicology and risk assessment of coumarin: focus on human data. Molecular Nutrition & Food Research, 54, 228–239.
3. Acharva, S. N., Basu, S. K., & Thomas, J. E. (2007). Medicinal properties of fenugreek (Trigonella foenum-graecum L.): a review of the evidence-based information. Advencement in Medicinal Plant Research, 81-122.
4. Aguirre, L., Arias, N., Macarulla, M. T., Gracia, A., & Portillo, M. P. (2011). Beneficial effects of quercetin on obesity and diabetes. The Open Nutraceuticals Journal, 4, 189-198.
5. Archer, A. (1988). Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography. Journal of Chromatography A, 447, 272–276.
6. Arıtuluk, Z. C., & Ezer, N. (2012). Halk arasında diyabete karşı kullanılan bitkiler (Türkiye)-II. Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi, 7 (2), 179-208.
7. Augusti, K. T., & Shella, C. G. (1996). Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue in diabetic rats. Experientia, 52, 115-120.
8. Başkal, N. (2005). Diabetes Mellitus’un Sınıflandırılması. Erdoğan, G. (Eds.) Koloğlu Endokrinoloji Temel ve Klinik, M. N. Medikal & Nobel, 342.

9. Bever, B. O., & Zahnd, G. R. (1979). Plants with oral hypoglycemic action. Quarterly Journal of Crude Drug Research, 17, 139-196.
10. Boaduo, N. K., Katerere, D., Eloff, J. N., & Naidoo, V. (2014). Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods. Pharmaceutical Biology, 52 (6), 756-761.
11. Borrelli, F., Capasso, R., & Izzo, A. A. (2007). Garlic (Allium sativum L.): Adverse effects and drug interactions in humans. Molecular Nutrition & Food Research, 51, 1386-1397.
12. Chen, L., Sun, P., Wang, T., Chen, K., Jia, Q., & Wang, H. (2012). Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. Journal of Agricultural and Food Chemistry, 60 (36), 9144-9150.
13. Cheng, D. M., Kuhn, P., Poulev, A., Rojo, L. E., Lila, M. A., & Raskin, I. (2012). In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix. Food Chemistry, 135 (4), 2994-3002.
14. Chericoni, S., Prieto, J. M., Iacopini, P., Cioni, P., & Morelli, I. (2005). In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite-induced oxidative processes. Journal of Agricultural and Food Chemistry, 53, 4762–4765.
15. Choi, K. (2008). Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacologica Sinica, 9, 1109-1118.
16. Demirezer, L. Ö. (2011). FFD Monografları Tedavide Kullanılan Bitkiler. 2nd ed. Ankara: MN Medikal & Nobel, 461-463.
17. European Medicines Agency (EMA), European Union herbal monograph on Vaccinium myrtillus L., fructus recens, 2015. Assessment report on Cinnamomum verum J.S. Presl, cortex and corticis aetheroleum, 2011. Herbal medicine: summary for the public, Ginseng root, 2017. Community herbal monograph on Zingiber officinale Roscoe, rhizoma, 2012.
18. Fuller, S., & Stephens, J. M. (2015). Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Advances in Nutrition, 6 (2), 189-197.
19. Green, A., Sjolie, A. K., & Eshoj, O. (1996). Trends in the epidemiology of IDDM during 1970-2020 in Fyn County, Denmark. Diabetes Care, 19, 801-806. https://doi.org/10.2337/diacare.19.8.801
20. Grundy, S.M., Howard, B., Smith, S. J., Eckel, R., Redberg, R., & Bonow, R. O. (2002). Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation, 105 (18), 2231-2239.
21. Gu, J., Li, W., Xiao, D., Wei, S., Cui, W., & Chen, W. (2013). Compound K, a final intestinal metabolite of ginsenosides, enhances insulin secretion in MIN6 pancreatic β-cells by upregulation of GLUT2. Fitoterapia, 87, 84-88. https://doi.org/10.1016/j.fitote.2013.03.020
22. Jain, D. P., Pancholi, S. S., & Patel, R. (2011). Synergistic antioxidant activity of green tea with some herbs. Journal of Advanced Pharmaceutical Technology & Research, 2 (3), 177-183. https://doi.org/10.4103/2231-4040.85538
23. He, K., Li, X., Chen, X., Ye, X., Huang, J., & Jin, Y. (2011). Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. Journal of Ethnopharmacology, 137 (3), 1135-1142.
24. Infrmary, R. (1995). The United Kingdom Prospective Diabetes Study Group: U.K. prospective diabetes study. 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes, 44, 1249–1258.
25. Jarald, E., Joshi, S. B., & Jain, D. C. H. (2012). Diabetes and herbal medicines. Iranian Journal of Pharmacology & Therapeutics, 7 (1), 97-106.
26. Kim, J. H., Pan, J. H., Cho, H. T., & Kim, Y.J. (2016). Black ginseng extract counteracts streptozotocin-induced diabetes in mice. PLoS One, 11 (1), 1-11.
27. Kirkham, S., Akilen, R., Sharma, S., & Tsiami, A. (2009). The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes, Obesity and Metabolism, 11 (12), 1100-1113.
28. Kirtikar, K. R., & Basu, B. D. (2003). Indian Medicinal Plants With Illustrations. 2. Edition. Dehradun: Oriental Enterprises, 982-983.
29. Koupy, D., Kotolova, H., & Ruda Kucerova, J. (2015). Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II. Fenugreek (Trigonella foenum-graecum). Ceska a Slovenska Farmacie, 64 (3), 67-71. Lean Teig, N., & Shu-Jing, W. (2011). Antiproliferative activity of Cinnamomum cassia constituents and effects of pifithrin-alpha on their apoptotic signaling pathways in Hep G2 Cells. Evidence-Based Complementary and Alternative Medicine, 492148. https://doi.org/10.1093/ecam/nep220
30. Lee, C. W., Lee, S. H., Lee, J. W., Ban, J. O., Lee, S. Y., & Yoo, H. S. (2007). 2-Hydroxycinnamaldehyde inhibits SW620 colon cancer cell growth through AP-1 Inactivation. Journal of Pharmacological Sciences, 104 (1), 19-28.
31. Leela, N. K., Chempakam, B., & Zachariah, T. J. (2008). Cinnamon and cassia. Parthasarathy VA. Chemistry of spices, Cabi, Wallingford, 7, 124-144.
32. Mandrup-Poulsen, T. (1998). Recent advances: BMJ Open Diabetes Research & Care, 316, 1221–1225.
33. Markey, O., McClean, C. M., Medlow, P., Davison, G. W., Trinik, T. R., & Duly, E. (2011). Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia and appetite responses to high-fat breakfast. Cardiovascular Diabetology, 7 (10), 78. https://doi.org/10.1186/1475-2840-10-78
34. Marks, J. B., & Raskin, P. (2000). Cardiovascular risk in diabetes: a brief review. Journal of Diabetes and its Complications, 14 (2), 108-115.
35. Medagama, A. B. (2015). The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutrition Journal, 14, 108. https://doi.org/10.1186/s12937-015-0098-9
36. Mishra, A., Bhatti, R., Singh, A., & Singh Ishar, M. P. (2010). Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Medica, 6 (5), 412-417.
37. Naidu, P. B., Ponmurugan, P., Begum, M. S., Mohan, K., Meriga, B., & Ravindar Naik, R. (2015). Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats. Journal of the Science of Food and Agriculture, 95 (15), 3177-3182.
38. Nathan, D. M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., & Davis, M. (1993). The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine, 329, 977–986.
39. Phani, R. S., Vinaykumar, C., Umamaheswara-Rao, K. U., & Sindhuja, G. (2010). Quantitative analysis of quercetin in natural sources by RP-HPLC. International Journal of Pharmaceutical and Biomedical Research, 1, 19-22.
40. Rafehi, H., Ververis, K., Karagiannis, T.C., & Contoversies, K. (2012). Surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes, Obesity and Metabolism, 14 (6), 493-499.
41. Ram, P. (1993). Compandium of Indian Medicinal Plants. Vol 2nd, 3rd, 4th. New Delhi, 659-660.
42. Ranasinghe, P., Jayawardana, R., Galappaththy, P., Constantine, G. R., de Vas Gunawardana, N., & Katulanda, P. (2012). Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabetic Medicine, 29 (12), 1480-1492.
43. Roberts, K. T. (2011). The potential of fenugreek (Trigonella foenum-graecum) as a functional food and nutraceutical and its effects on glycemia and lipidemia. Journal of Medicinal Food, 14 (12), 1485-1489.
44. Saravanan, G., & Ponmurugan, P. (2010). Beneficial effect of S-allylcysteine (SAC) on blood glucose and pancreatic antioxidant system in streptozotocin diabetic rats. Plant Foods for Human Nutrition, 65 (4), 374-378.
45. Satman, I., Yilmaz, T., Sengül, A., Salman, S., Salman, F., Uygur, S., Bastar, I., Tütüncü, Y., Sargin, M., Dinççag, N., Karsidag, K., Kalaça, S., Ozcan, C., & King, H. (2002). Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care, 25 (9), 1551-1556.
46. Sheela, C. G., & Augusti, K. T. (1992). Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian Journal of Experimental Biology, 30, 523-526.
47. Shen, Q., Chen, F., & Luo, J. (2002). Comparison studies on chemical constituents of essential oil from ramulus cinnamomi and cortex cinnamomi by GC-MS. Zhong Yao Cai, 25, 257–258.
48. Shin, H. R., Kim, J. Y., Yun, T. K., Morgan, G., & Vainio, H. (2000). The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes and Control, 11, 565-576.
49. Simic, A., Sokovic, M. D., Ristic, M., Grujic-Jovanovic, S., Vukojevic, J., & Marin, P. D. (2004). The chemical composition of some Lauraceae essential oils and their antifungal activities. Phytotherapy Research, 18, 713–717.
50. Singh, G., Maurya, S., DeLampasona, M. P., & Catalan, C. A. (2007). A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. Food and Chemical Toxicology, 45, 1650–1661.
51. Usta, J., Kreydiyyeh, S., Barnabe, P., Bou-Moughlabay, Y., & Nakkash-Chmaisse, H. (2003). Comparative study on the effect of cinnamon and clove extracts and their main components on different types of ATPases. Human & Experimental Toxicology, 22, 355–362.
52. Verspohl, E. J., Bauer, K., & Neddermann, E. (2005). Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytotherapy Research, 19 (3), 203-206.
53. Wei, S., Li, W., Yu, Y., Yao, F., & Lan, X. (2015). Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase. Life Sciences, 139, 8-15.
54. WHO (World Health Organisation) (1999a). Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Con-sultation: Part 1 Diagnosis and classification of diabetes mellitus, WHO, Geneva.
55. WHO (World Health Organisation) (1999b). Monographs on Selected Medicinal Plants, Vol. 1, Radix Ginseng. Geneva: 1999;168-178, Cortex Cin-namomi; 95-102, Bulbus Allii sativi; 16-26, Bulbus Allii cepae; 5-12, Rhizoma Zingiberis; 277-285. WHO Monographs on Selected Medicinal Plants, Vol. 4, Fructus Momordicae; 192-206, Fructus Myrtilli; 210-222.
56. Zafar, M. I., & Gao, F. (2016). 4-Hydroxyisoleucine: A potential new treatment for type 2 diabetes mellitus. BioDrugs, 30 (4), 255-262.